Cite
Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral Therapy.
MLA
Berenguer, Juan, et al. “Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral Therapy.” Clinical Infectious Diseases, vol. 76, no. 6, Mar. 2023, pp. 977–85. EBSCOhost, https://doi.org/10.1093/cid/ciac880.
APA
Berenguer, J., Jarrín, I., Bellón, J. M., Díez, C., Jiménez-Sousa, M. A., Roca, C., González-García, J., Dalmau, D., Olalla, J., Herrero, C., Villarroya, F., Domingo, P., & Resino, S. (2023). Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral Therapy. Clinical Infectious Diseases, 76(6), 977–985. https://doi.org/10.1093/cid/ciac880
Chicago
Berenguer, Juan, Inmaculada Jarrín, José M Bellón, Cristina Díez, María A Jiménez-Sousa, Cristina Roca, Juan González-García, et al. 2023. “Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral Therapy.” Clinical Infectious Diseases 76 (6): 977–85. doi:10.1093/cid/ciac880.